US 12275685
Oligo-benzamide analogs and their use in cancer treatment
granted A61PA61P35/00
Quick answer
US patent 12275685 (Oligo-benzamide analogs and their use in cancer treatment) held by The Board of Regents of the University of Texas System expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Apr 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61P, A61P35/00